We are live on ! Find out more
PSTV icon

Plus Therapeutics

11 hedge funds and large institutions have $247K invested in Plus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more capital invested

Capital invested by funds: $118K → $247K (+$130K)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

10% more funds holding

Funds holding: 1011 (+1)

0% more ownership

Funds ownership: 0.12%0.12% (+0%)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$58K +$52.9K +1,320 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$57K +$26.2K +654 +101%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$47.5K
Citadel Advisors
4
Citadel Advisors
Florida
$30.1K +$27K +674 New
GSC
5
Ground Swell Capital
South Carolina
$25.6K +$22.9K +572 New
UBS Group
6
UBS Group
Switzerland
$15.6K +$6.01K +150 +73%
BlackRock
7
BlackRock
New York
$12.2K
TRCT
8
Tower Research Capital (TRC)
New York
$1K -$1.4K -35 -60%
Osaic Holdings
9
Osaic Holdings
Arizona
$232
JP Morgan Chase
10
JP Morgan Chase
New York
$177 +$160 +4 New
Wells Fargo
11
Wells Fargo
California
$61
Group One Trading
12
Group One Trading
Illinois
$2
Millennium Management
13
Millennium Management
New York
-$26.5K -790 Closed
HF
14
HRT Financial
New York
-$15K -449 Closed
Citigroup
15
Citigroup
New York
-$776 -23 Closed